Status:
UNKNOWN
The Efficacy of Platelets Rich Plasma Injection With PRGF Method in the Treatment for Osteoarthritis of the Subtalar Joint
Lead Sponsor:
Meir Medical Center
Conditions:
Osteoarthritis of Subtalar Joint
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The investigators will try to find any efficacy of platelet rich plasma injection for the treatment of osteoarthritis (OA) in the subtalar joint. Autologous platelet-secreted growth factors (GFs) may ...
Detailed Description
The therapeutic use of autologous platelet-rich plasma (PRP) constitutes a relatively new biotechnology that has been a breakthrough in the stimulation and acceleration of soft-tissue and bone healing...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female age 18-70
- Diagnosed OA of subtalar joint
- Patients who didn't benefit from other conservative treatments
- Patients who are willing to participate in the trial
- Exclusion criteria:
- Non ambulatory
- Pregnant or lactating women
- Patient with containment disease that may affect joint
- Patient with open wounds; or skin disease; suspected joint infection: in the treated area
- Patients with a specific condition or poor general health status that will interfere with the functional assessments during the study or who had intraarticular injection or have had surgery within the previous 3 months
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01422460
Start Date
August 1 2011
End Date
June 1 2013
Last Update
August 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir medical center
Kfar Saba, Israel